Inhaled Steroid Treatment as Regular Therapy in Early Asthma - START

Study identifier:SD-004-0111

ClinicalTrials.gov identifier:NCT00641914

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Inhaled Steroid Treatment As Regular Therapy in Early Asthma. A study on the effect of early intervention with long-term inhaled Budesonide (Pulmicort Turbuhaler ® ) in newly diagnosed asthma.

Medical condition

asthma

Phase

Phase 4

Healthy volunteers

Study drug

budesonide, Placebo

Sex

All

Actual Enrollment

6800

Study type

Interventional

Age

6 Years - 60 Years

Date

Study Start Date: 01 Oct 1996

Primary Completion Date: 01 Feb 2003

Study Completion Date: 01 Feb 2003

Study design

Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Dec 2016 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
Experimental: 1	-
Placebo Comparator: 2	-

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1096&filename=CSR-SD-004-0111.pdf
Download
CSR-SD-004-0111.pdf
Download
redacted CSP
Download
Trial Results Summaries
Available here

Contacts

Contact

null AstraZeneca Clinical Study Information

800-236-9933

[email protected]

Investigators

Principal Investigator

Romain Pauwels

Steering Committee Chairman